Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in San Diego, California and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Follow-Up Questions
¿Quién es el CEO de Ainos Inc?
Mr. Chun-Hsien Tsai es el Chairman of the Board de Ainos Inc, se unió a la empresa desde 2021.
¿Qué tal es el rendimiento del precio de la acción AIMD?
El precio actual de AIMD es de $4.02, ha increased un 1.25% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Ainos Inc?
Ainos Inc pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Ainos Inc?
La capitalización bursátil actual de Ainos Inc es $19.1M